IOTA Pharmaceuticals

Email Usinfo@iotapharma.com

Call Us+ 44 1223 421430

IOTA Pharmaceuticals

 
Fragment - based Drug Discovery
Neglected Parasitic Disease
Glioma & Glioblastoma
 
 
About IOTA Drug Descovery and Development Partnership

IOTA's Drug Discovery Partnerships are designed for groups seeking to move rapidly and cost effectively from validated target to hit molecules or looking to find new hits within novel, patentable chemical space.

Whether your target has structural information or only information about existing ligands or even just low affinity fragments, IOTA’s screening tools can identify lead fragments, incorporate these into novel scaffold structures, and design potent, selective, and orally bioavailable lead compounds.

For more information contact info@iotapharma.com

RSS